VDR and metabolic dysfunction-associated steatotic liver disease: ANGPTLs were novel transcription targets of VDR and activated VDR upregulated hepatic and systemic ANGPTLs expression in NAFLD patients, thus increasing lipid synthesis and intrahepatic fat accumulation and aggravating liver fibrosis (21).